Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
3930363 | European Urology Supplements | 2011 | 6 Pages |
Abstract
Surveillance, adjuvant chemotherapy, and ns-RPLND are all accepted treatments for long-term survival. The ns-RPLND has similar merits to surveillance and adjuvant chemotherapy and should be presented to patients as an equal option.
Related Topics
Health Sciences
Medicine and Dentistry
Obstetrics, Gynecology and Women's Health
Authors
Mert Gunay, Bulent Akdogan, Cemil Uygur, Haluk Ãzen,